Skip to main content

MINOCA

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
CONFIRM Rx implantable cardiac rhythm monitorN/A1 trial
Active Trials
NCT05326828Recruiting60Est. May 2031

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
AbbottCONFIRM Rx implantable cardiac rhythm monitor

Clinical Trials (1)

Total enrollment: 60 patients across 1 trials

NCT05326828AbbottCONFIRM Rx implantable cardiac rhythm monitor

Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA

Start: May 2022Est. completion: May 203160 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 60 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.